00:00 – Introduction
03:19 – The First Technology
06:52 – The Second Technology Lateral Tunnel Fontan {LTF} Process
10:46 – The Hemi-Fontan {HF} Operation
16:34 – Third Technology-The Additional-Cardiac Conduit Fontan Process (ECC)
22:51 – Fourth Technology – The Intra / Additional Cardiac Fontan (IECF)
27:16 – Idea of Fenestration
Up till the mid-1900’s, tricuspid atresia – a beginning defect of the tricuspid valve, was as soon as categorized as a “loss of life sentence.” The problem of reaching constructive well being outcomes for affected sufferers was compounded by a hesitancy to function on youngsters. The principle concern was safely administering anesthesia to younger sufferers who have been going by a strenuous operation that was typically poorly tolerated. Regardless of these assumed limitations, Francis Fontan, a pediatric cardiothoracic surgeon on the Hospital of Tondu in Bordeaux, was in a position to redirect blood circulation from the superior and inferior vena cava to the pulmonary arteries in 1971, which elucidated the method of advancing medical apply in drugs. With the assist of mentors and a agency perception on this new method, Fontan pioneered his eponymous process and in the end paved the way in which for contemporary cardiovascular surgical strategies that helped to extend the lifetime of these with single functioning ventricles. The intention of this examine is to look at the genesis and the evolution of the Fontan process to elucidate the method of advancing medical apply in drugs by using private interviews, Fontan’s works, related major and secondary sources within the context of twentieth century cardiothoracic surgical procedure and improvements.
